Clinical factors affecting the therapeutic dose window in cervical cancer brachytherapy: A systematic review and meta-regression
Studies using interstitial needles with T&R applicators in MR-guided brachytherapy for cervical cancer seem to be associated with a favorable therapeutic target dose/OAR sparing ratio.
Authors
- Remi A. Nout (ORCID: https://orcid.org/0000-0001-8011-2982)
- Linda Wauben (ORCID: https://orcid.org/0000-0002-6125-9812)
- Robin Straathof (ORCID: https://orcid.org/0000-0002-0396-8880)
- S. van Vliet-Pérez
- Ben Heijmen (ORCID: https://orcid.org/0000-0003-1647-0528)
- Henrike Westerveld
- Lotte I. Pool
- Nick J. van de Berg
- Inger-Karine K. Kolkman-Deurloo
- Jenny Dankelman
Institutions
- Erasmus MC Cancer Institute (NL)
- Delft University of Technology (NL)
Publication Details
- Journal
- Brachytherapy
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.brachy.2025.11.005
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Accuray
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek